Search icon

RIVERSIDE RESEARCH INSTITUTE

Headquarter
Company claim

Is this your business?

Get access!

Company Details

Name: RIVERSIDE RESEARCH INSTITUTE
Jurisdiction: New York
Legal type: DOMESTIC NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 05 May 1967 (58 years ago)
Entity Number: 209809
ZIP code: 12207
County: New York
Place of Formation: New York
Address: 80 STATE STREET, ALBANY, NY, United States, 12207

Agent

Name Role Address
CORPORATION SERVICE COMPANY Agent 80 STATE STREET, ALBANY, NY, 12207

DOS Process Agent

Name Role Address
C/O CORPORATION SERVICE COMPANY DOS Process Agent 80 STATE STREET, ALBANY, NY, United States, 12207

Links between entities

Type:
Headquarter of
Company Number:
000-788-756
State:
Alabama
Type:
Headquarter of
Company Number:
97ff6ffb-0f5b-ef11-9085-00155d01c440
State:
MINNESOTA
Type:
Headquarter of
Company Number:
19991193273
State:
COLORADO
Type:
Headquarter of
Company Number:
CORP_69980732
State:
ILLINOIS

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
KHFHVA9JWAW9
CAGE Code:
2P643
UEI Expiration Date:
2026-03-19

Business Information

Activation Date:
2025-03-21
Initial Registration Date:
2002-02-01

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
2A454
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-03-27
CAGE Expiration:
2030-03-27
SAM Expiration:
2026-03-25

Contact Information

POC:
MARY BAREFOOT

Immediate Level Owner

Vendor Certified:
2025-03-27
CAGE number:
1G356
Company Name:
RIVERSIDE RESEARCH INSTITUTE

History

Start date End date Type Value
2019-01-28 2024-06-18 Address 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent)
2019-01-28 2024-06-18 Address 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Service of Process)
2010-10-04 2019-01-28 Address 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process)
1999-09-16 2010-10-04 Address 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process)
1999-09-16 2019-01-28 Address 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Registered Agent)

Filings

Filing Number Date Filed Type Effective Date
240618000898 2024-06-18 CERTIFICATE OF CHANGE BY ENTITY 2024-06-18
SR-2653 2019-01-28 CERTIFICATE OF CHANGE 2019-01-28
SR-2652 2019-01-28 CERTIFICATE OF CHANGE 2019-01-28
101004000586 2010-10-04 CERTIFICATE OF AMENDMENT 2010-10-04
990916000120 1999-09-16 CERTIFICATE OF CHANGE 1999-09-16

USAspending Awards / Contracts

Procurement Instrument Identifier:
FA855524F0031
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
0.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-10-01
Description:
SERVICES SPECIAL PROJECTS ENGINEERING SUPPORT SERVICES
Naics Code:
541330: ENGINEERING SERVICES
Product Or Service Code:
R425: SUPPORT- PROFESSIONAL: ENGINEERING/TECHNICAL
Procurement Instrument Identifier:
FA865021C1150
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
20000.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2020-11-09
Description:
OPTICS, PLASMA TECHNOLOGY AND ELECTRO-MAGNETIC ANTENNA STRUCTURES
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AC12: NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
Procurement Instrument Identifier:
N0001420C1114
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
0.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2020-09-29
Description:
EXTENDING THE AURORA ASYMPTOTIC EM MODEL TO ADDRESS PROBLEMS OF INTEREST TO THE US NAVY
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AD92: R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

USAspending Awards / Financial Assistance

Date:
2021-09-21
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
VITREO-RETINAL DISEASE IMAGING WITH 3D ANNULAR-ARRAY ULTRASOUND - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS TRANSLATIONAL PROJECT IS TO ADD QUANTITATIVE ULTRASOUND (QUS) CAPABILITIES TO A CLINICAL OPHTHALMIC ULTRASOUND SYSTEM IN ORDER TO CHARACTERIZE VITREOUS INHOMOGENEITY (I.E., CLINICALLY SIGNICANT VITREOUS OATERS RE- FERRED TO AS VISION DEGRADING MYODESOPSIA) AS IT RELATES TO STATES OF HEALTH AND DISEASE. AGE-RELATED CHANGES DUE TO COLLAGEN CROSS-LINKING AND AGGREGATION WITH LIQUEFACTION CREATE INHOMOGENEITIES THAT APPEAR NON-UNIFORMLY THROUGHOUT THE VITREOUS BODY. FOR PATIENTS WITH MYOPIA THESE PROCESSES OCCUR EARLIER IN LIFE, WHEN VITREO-RETINAL ADHESION IS STILL STRONG, AND DESTABILIZE THE VITREOUS BODY BEFORE ADHESION TO THE RETINA IS WEAKENED, RESULTING IN A VARIETY OF CONDITIONS THAT IMPACT VISION. THE ABILITY TO DEPICT VITREO-RETINAL ORGANIZATION WILL OFFER UNIQUE EARLY STAGE DETECTION AND ASSESSMENT OF VITREO-RETINAL DISEASE IN PATIENTS WITH MYOPIA AT RISK FOR RETINAL DETACHMENT AND VITREO-MACULOPATHIES RESULTING FROM TRACTION.. CURRENTLY, NO DIAGNOSTIC METHOD IS AVAILABLE TO MAKE DATA-BASED DECISIONS RELATED TO THE CHANGES TAKING PLACE IN THE VITREOUS BODY BEFORE BLINDING PATHOLOGIES HAVE DEVELOPED. THE IMPENDING EPIDEMIC OF MYOPIA HAS CREATED AN URGENT CLINICAL NEED FOR TECHNOLOGIES OFFERING OBJECTIVE AND SENSITIVE MEANS FOR EARLY DETECTION OF MACROMOLECULAR CHANGES AND STRUCTURAL PRECURSORS IN THE VITREOUS BODY DIRECTLY RELATED TO VITREO-RETINAL DISEASES. A DIAGNOSTIC TOOL CAPABLE OF QUANTITATIVELY CHARACTERIZING THE ENTIRE VITREOUS BODY WOULD ASSIST IN DEVELOPING LESS INVASIVE AND AFFORDABLE TREATMENTS FOR EARLY INTERVENTION, SUCH AS PHARMACOLOGIC VITREOLYSIS OR LASER THERAPY, AND FOR IDENTIFYING PATIENTS IN NEED OF MORE AGGRESSIVE INTERVENTIONS WITH VITRECTOMY. IN COLLABORATION WITH QUANTEL MEDICAL, WE WILL INCORPORATE A NEW 3D PROBE AND QUS CAPABILITIES INTO A STATE-OF- THE ART, 20-MHZ ANNULAR-ARRAY-BASED CLINICAL OPHTHALMIC ULTRASOUND SYSTEM. THE EARLY STAGES OF THE PROJECT WILL EMPHASIZE DEVICE ENHANCEMENTS TO OBTAIN NECESSARY RAW ULTRASOUND DATA FOLLOWED BY AGE-NORMAL AND MYOPIC PATIENT DATA COLLECTION AND DEVELOPMENT OF QUS ALGORITHMS TO CHARACTERIZE THE VITREOUS BODY IN 2D. THE LATER STAGES OF THE PROJECT WILL FOCUS ON DEVELOPMENT AND INTEGRATION OF A PROBE CAPABLE OF VOLUMETRIC ACQUISITION, FURTHER PATIENT DATA COLLECTION, AND QUS CLASSICATION METHODS THAT TAKE ADVANTAGE OF THE NEW VOLUMETRIC DATA. THE NAL SYSTEM WILL PERMIT QUANTITATIVE CHARACTERIZATION OF THE VITREOUS BODY AND ALLOW FOR DATA-BASED TREATMENT DECISIONS OF VITREO-RETINAL DISEASES. WHILE THIS INVESTIGATION WILL FOCUS ON MYOPIA, THE RESULTANT TECHNOLOGY AND APPROACH WILL HAVE THE POTENTIAL FOR APPLICATION IN MANY DIFFERENT CLINICAL SETTINGS.
Obligated Amount:
2166847.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-09-12
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
NOVEL IN-VIVO ULTRASOUND-BASED POINT-OF-CARE INSTRUMENT TO ASSESS MYOPIA LEVEL AND PROGRESSION
Obligated Amount:
423857.38
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-08-23
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
FINE-RESOLUTION MAPPING OF MICRO VASCULATURE AFTER PLACENTAL TRANSPORT OF ACOUSTIC NANODROPS
Obligated Amount:
441610.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-01-25
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
NOVEL QUANTITATIVE ULTRASOUND METHODS FOR IN-VIVO HISTOMORPHOLOGY TO GRADE EARLY CARTILAGE DEGENERATION
Obligated Amount:
332938.31
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2018-08-16
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
IMAGING OF PROSTATE CANCER BY COMBINED QUANTITATIVE ULTRASOUND AND ACOUSTIC-RADIATION-FORCE-IMPULSE IMAGING
Obligated Amount:
155080.61
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 18 Mar 2025

Sources: New York Secretary of State